Colloquium on new antituber culosis drugs. Criteria for assaying new antituber culosis drugs, evaluation of kanamycin, d-cycloserine and ethylthioisonicotinamide in the therapy of pulmonary tuberculosis.
D000995:Antitubercular Agents / Q000494:pharmacology*; D001681:Biological Assay; D003523:Cycloserine; D006801:Humans; D007612:Kanamycin; D014397:Tuberculosis, Pulmonary
D000995:Antitubercular Agents; D007612:Kanamycin; D003523:Cycloserine
ANTITUBERCULAR AGENTS/pharmacology